What question did this study set out to answer?

This research aims to investigate the incidence of Acinetobacter baumannii isolates and their antimicrobial resistance in hospitalized patients.

December 8, 2025JAC-Antimicrobial ResistanceOpen Access

P27 Carbapenem-resistant Acinetobacter baumannii : a challenge in the intensive care units

View Full Paper

Ask AI

Bookmark

Authors

RBRrezarta Bajrami ADAida Duriqi

Discussion

Member takes

Implication

Laboratory-based evaluation reveals high rates of antibiotic resistance in carbapenem-resistant Acinetobacter baumannii isolates from ICU patients, suggesting urgent infection control measures.

Key Points

This research aims to investigate the incidence of Acinetobacter baumannii isolates and their antimicrobial resistance in hospitalized patients.
Conducted a laboratory-based evaluation study in 2024 at the University Clinical Center of Kosovo (UCCK)
Isolated and identified A. baumannii from clinical samples, especially from ICU patients
Performed antimicrobial susceptibility testing using standard methods like VITEK® and BD Phoenix™
Assessed resistance genes using eazyplex and Unyvero
Collected 838 A. baumannii isolates, with 96.65% resistant to carbapenems, indicating high multidrug-resistance rates
High frequency of isolates from respiratory sources and intensive care units
Colistin remained effective in 97.85% of isolates, critical for treating MDR A. baumannii
Identified significant presence of resistance genes including NDM, OXA-23, OXA-48, and OXA 24-40

Cite This Study

Bajrami et al. (2025) studied this question.

synapsesocial.com/papers/693624984fa91c937236c017 https://doi.org/10.1093/jacamr/dlaf230.034

View Full Paper

Ask AI

Bookmark

Implication

Laboratory-based evaluation reveals high rates of antibiotic resistance in carbapenem-resistant Acinetobacter baumannii isolates from ICU patients, suggesting urgent infection control measures.